Douglas Woseth, MD
Dermatology · Salt Lake, UTNPI 1619978970
Payments from drug & device makers
Across 471 payments — averaging $988.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$331K
- Eli Lilly$41K
- Galderma Laboratories, L.p.$37K
- Incyte Corporation$28K
- Teva Pharmaceuticals USA, Inc.$19K
- Sun Pharmaceutical Industries Inc.$7K
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 153 | $330,656 |
| Eli Lilly | 3 | $41,075 |
| Galderma Laboratories, L.p. | 30 | $36,869 |
| Incyte Corporation | 41 | $28,044 |
| Teva Pharmaceuticals USA, Inc. | 2 | $18,750 |
| Sun Pharmaceutical Industries Inc. | 14 | $6,740 |
| Johnson & Johnson | 34 | $655 |
| Pfizer | 55 | $602 |
| Novartis | 34 | $554 |
| UCB, Inc. | 17 | $391 |
| Sanofi | 10 | $195 |
| Lilly USA, LLC | 11 | $183 |
| LEO Pharma Inc. | 8 | $176 |
| Arcutis Biotherapeutics, Inc. | 16 | $150 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $123 |
| Dermavant Sciences, Inc. | 5 | $91 |
| Amgen | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 4 | $63 |
| Genentech USA, Inc. | 4 | $62 |
| VYNE Pharmaceuticals Inc. | 3 | $44 |
| Prugen, Inc. Pharmaceuticals | 1 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Organon | 3 | $35 |
| Botanix SB Inc | 2 | $32 |
| Merz North America, Inc. | 2 | $29 |
| Mylan Pharmaceuticals Inc. | 2 | $26 |
| Journey Medical Corporation | 1 | $26 |
| Biofrontera Inc. | 1 | $19 |
| EPI Health, LLC | 1 | $16 |
How this compares
$465,758 in reported general payments places this provider in the 90th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Salt Lake
- Jamie RhoadsMurray$2.5M
- Doug Lass ForshaWest Jordan$2.2M
- Michael PetersonSpanish Fork$1.6M
- Kristina DuffinSalt Lake City$1.2M
- Gerald KruegerSalt Lake City$1.1M
- Brian WilliamsMidvale$876K
- Jason HadleyBountiful$477K
- Mark TaylorSalt Lake City$473K
- Travis JamesProvidence$472K
- James MacdonaldLehi$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.